War on Cancer: Some Doctors Are Using the Word 'Cure'

The video discusses the evolving concept of a cancer cure, highlighting new therapies that boost the immune system. Companies like Merck and Bristol Myers are leading the development of checkpoint inhibitors, while biotechs like Kite and Juno focus on CAR T therapies. These treatments show promise, with some patients reaching the five-year cancer-free mark. However, challenges remain in understanding why only certain patients respond. The video also covers the financial impact on companies and the upcoming cancer conference in Chicago, which will discuss new data and long-term patient outcomes.

What is the challenge that oncologists face regarding patient responses to therapies?

What types of data are being sought at the upcoming cancer conference?